Guidance Document: Certificate of Supplementary Protection Regulations - summary 

From Health Canada

Overview

This guidance document provides an overview of the certificate of supplementary (CSP) application process for applicants. This includes information on

  • how to provide a CSP application
  • the service standard for processing applications
  • the roles and responsibilities of applicants and the Therapeutic Products Directorate (TPD)

Please note our new email address to which CSP applications are to be submitted:  hc.opml-bmbl.sc@canada.ca

Please note our new CSP Application form having a 12 month timely submission attestation, which must be used on or after September 22, 2018.

Who this guide is for

  • Owners of Canadian patents
  • Canadian and foreign drug companies
  • Canadian and foreign regulatory bodies

In this guide

View complete guide
Download PDF (331 KB, 24 pages)

Details and history

Published: September 21, 2017

Updated: September 4, 2018

Part of topic(s): Guidance on Certificates of Supplementary Protection

For assistance

Questions or concerns related to this Guidance Document should be directed to the Office of Patented Medicines and Liaison.

Contact us by email: hc.opml-bmbl.sc@canada.ca

Contact us by mail:  

Office of Submissions and Intellectual Property
Finance Building 
101 Tunney's Pasture Driveway
Address Locator: 0201A1
Ottawa, Ontario
K1A 0K9

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: